The most common side effects reported in patients receiving a single 150 mg dose of this drug for vaginitis were headache, nausea, and During clinical trials of multiple-dose therapy, side effects were reported in 16% of patients.
Ann Intern Med 113 (1990): 89941.
Ce médicament est disponible sous divers noms de marque ou sous différentes présentations, ou les deux.Une marque … Les effets secondaires énumérés ci-après ne sont pas ressentis par toutes les personnes qui prennent ce médicament.
Il est important d'utiliser ce médicament conformément aux indications de votre médecin ou de votre pharmacien.
N Engl J Med 326 (1992): 83-910. J Am Acad Dermatol 35 (1996): 28437. Lancet 338 (1991): 63331.
The most common side effects reported in patients receiving a single 150 mg dose of this drug for vaginitis were headache, nausea, and abdominal pain.
J Am Acad Dermatol 32 (1995): 525-639. Mercurio MG, Elewski BE "Thrombocytopenia caused by fluconazole therapy." McMahon JH, Grayson ML "Torsades de pointes in a patient receiving fluconazole for cerebral cryptococcosis."
Clin Chest Med 30 (2009): 203-15, v8.
AIDS 6 (1992): 191-425.
Wells C, Lever AM "Dose-dependent fluconazole hepatotoxicity proven on biopsy and rechallenge ." Ann Intern Med 123 (1995): 354-727.
J Infect 24 (1992): 111-220. 5. Cerner Multum, Inc. "Australian Product Information." 2.
Neuhaus G, Pavic N, Pletscher M "Anaphylactic reaction after oral fluconazole." Esch JJ, Kantoch MJ "Torsades de pointes ventricular tachycardia in a pediatric patient treated with fluconazole."
Ann Intern Med 125 (1996): 15329.
Pediatr Cardiol 29 (2007): 210-336. Agarwal A, Sakhuja V, Chugh KS "Fluconazole-induced thrombocytopenia."
Holechek MJ "Medication review: fluconazole." Franklin IM, Elias E, Hirsch C "Fluconazole-induced jaundice."
Dermatol Clin 21 (2003): 469-79, vi7.
Clinical side effects were reported more often in Rare cases of seizures have been reported, but a causal relationship was difficult to establish, since some of these patients had cryptococcal Seizures, dizziness, paresthesia, somnolence, tremor, and Fatal hepatic reactions have occurred primarily in patients with serious underlying medical conditions (primarily AIDS or malignancy) and often taking multiple concomitant medications. Br J Clin Pract 44 (1990): 219-2211. Shear NH "Alopecia associated with fluconazole therapy." Ikemoto H "A clinical study of fluconazole for the treatment of deep mycoses." any side effects not listed in this leaflet, please tell your doctor or pharmacist. You may report them to the The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Serum transaminase elevations have been reported primarily in patients with serious underlying medical conditions (primarily AIDS or malignancy) and often taking multiple concomitant medications, including agents known to be hepatotoxic.Transaminase elevations greater than 2 to 3 x ULN have also been reported.Cholestasis, hepatocellular damage, and hepatocellular necrosis have also been reported during postmarketing experience.Reversible alopecia has been associated with long-term (2 months or longer) therapy.In patients with serious underlying diseases (primarily AIDS and malignancy), exfoliative skin disorders have resulted in a fatal outcome.Acute generalized exanthematous pustulosis, drug eruption, increased sweating, exfoliative skin disorders (including Stevens-Johnson syndrome, toxic epidermal necrolysis), and alopecia have also been reported during postmarketing experience.Rare cases of exfoliative dermatitis and ulcerative eruptions consistent with Stevens-Johnson syndrome have been reported in association with hypersensitivity reactions.A 52-year-old female experienced a fixed drug eruption (FDE) when administered a single 400 mg oral dose for extensive Most reports of QT interval prolongation and torsades de pointes involved seriously ill patients with multiple confounding risk factors, such as structural heart disease, electrolyte abnormalities, and concomitant medications that may have been contributory.QT prolongation and torsade de pointes have also been reported during postmarketing experience.Anemia, eosinophilia, leukopenia, neutropenia, and thrombocytopenia have been reported, often in patients with severe deep fungal infections or underlying disease.Spontaneous reports of anemia were more frequent in patients 65 years of age or older than in those between 12 and 65 years of age; however, there is a natural increase in the incidence of anemia in the elderly. Am J Gastroenterol 91 (1996): 165-822.